These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 8872907

  • 1. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
    Yu M, Johnson JM, Tuohy VK.
    J Neurosci Res; 1996 Aug 15; 45(4):463-70. PubMed ID: 8872907
    [Abstract] [Full Text] [Related]

  • 2. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel RP.
    J Exp Med; 1999 Apr 05; 189(7):1033-42. PubMed ID: 10190894
    [Abstract] [Full Text] [Related]

  • 3. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M, Johnson JM, Tuohy VK.
    J Exp Med; 1996 Apr 01; 183(4):1777-88. PubMed ID: 8666934
    [Abstract] [Full Text] [Related]

  • 4. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD.
    J Exp Med; 1995 Jul 01; 182(1):75-85. PubMed ID: 7540658
    [Abstract] [Full Text] [Related]

  • 5. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD.
    J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809
    [Abstract] [Full Text] [Related]

  • 6. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H.
    J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
    Karpus WJ, Kennedy KJ, Smith WS, Miller SD.
    J Neurosci Res; 1996 Aug 15; 45(4):410-23. PubMed ID: 8872901
    [Abstract] [Full Text] [Related]

  • 8. Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice.
    Tuohy VK, Thomas DM, Haqqi T, Yu M, Johnson JM.
    Autoimmunity; 1995 Aug 15; 21(3):203-14. PubMed ID: 8822278
    [Abstract] [Full Text] [Related]

  • 9. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF, Vandenbark AA, Offner H.
    J Neurosci Res; 1996 Sep 15; 45(6):680-9. PubMed ID: 8892079
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
    Tuohy VK, Yu M, Yin L, Mathisen PM, Johnson JM, Kawczak JA.
    J Neuroimmunol; 2000 Nov 01; 111(1-2):55-63. PubMed ID: 11063821
    [Abstract] [Full Text] [Related]

  • 11. Encephalitogenic T cells are present in Lewis rats protected from autoimmune encephalomyelitis by coimmunization with MBP73-84 and its analog.
    Stepaniak JA, Gould KE, Swanborg RH.
    J Neurosci Res; 1996 Aug 15; 45(4):447-54. PubMed ID: 8872905
    [Abstract] [Full Text] [Related]

  • 12. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
    Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel PR.
    J Autoimmun; 1999 Aug 15; 13(1):11-20. PubMed ID: 10441163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
    Tuohy VK, Thomas DM.
    J Neuroimmunol; 1995 Feb 15; 56(2):161-70. PubMed ID: 7532182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
    Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H.
    J Neurosci Res; 1996 Aug 15; 45(4):430-8. PubMed ID: 8872903
    [Abstract] [Full Text] [Related]

  • 17. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
    al-Sabbagh A, Miller A, Santos LM, Weiner HL.
    Eur J Immunol; 1994 Sep 15; 24(9):2104-9. PubMed ID: 7522160
    [Abstract] [Full Text] [Related]

  • 18. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
    Carrizosa AM, Nicholson LB, Farzan M, Southwood S, Sette A, Sobel RA, Kuchroo VK.
    J Immunol; 1998 Oct 01; 161(7):3307-14. PubMed ID: 9759846
    [Abstract] [Full Text] [Related]

  • 19. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD.
    J Clin Invest; 1999 Sep 01; 104(5):599-610. PubMed ID: 10487774
    [Abstract] [Full Text] [Related]

  • 20. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice.
    Fritz RB, Zhao ML.
    J Neurosci Res; 1996 Aug 15; 45(4):471-4. PubMed ID: 8872908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.